| 发明名称 |
Tablet formulation of a phosphatidylinositol 3-kinase inhibitor |
| 摘要 |
The present invention is directed to compositions and methods that target the PI3K signaling pathway for the treatment or prevention of cancer. In one aspect, there is provided a pharmaceutical formulation comprising Polymorph E of N-(3-{[(2Z)-3-[(2-chloro-5-methoxyphenyl)amino]quinoxalin-2(1H)-ylidene]sulfamoyl}phenyl)-2-methylalaninamide. |
| 申请公布号 |
US9364475(B2) |
申请公布日期 |
2016.06.14 |
| 申请号 |
US201514645947 |
申请日期 |
2015.03.12 |
| 申请人 |
SANOFI |
发明人 |
Parikh Darshan;Raju Praveen |
| 分类号 |
A61K31/498;A61K9/28;A61K9/20;A61K31/337;A61K45/06;A61K31/517;A61K31/555 |
主分类号 |
A61K31/498 |
| 代理机构 |
|
代理人 |
Morrill Brian R. |
| 主权项 |
1. A pharmaceutical formulation comprising Polymorph E of N-(3-{[(2Z)-3-[(2-chloro-5-methoxyphenyl)amino]quinoxalin-2(1H)-ylidene]sulfamoyl}phenyl)-2-methylalaninamide, a hydrogel polymer and a diluent. |
| 地址 |
Paris FR |
